000143232 001__ 143232
000143232 005__ 20240229112545.0
000143232 0247_ $$2doi$$a10.1038/s41375-018-0287-6
000143232 0247_ $$2pmid$$apmid:30323357
000143232 0247_ $$2ISSN$$a0887-6924
000143232 0247_ $$2ISSN$$a1476-5551
000143232 037__ $$aDKFZ-2019-00831
000143232 041__ $$aeng
000143232 082__ $$a610
000143232 1001_ $$0P:(DE-He78)a3903480c7232195efbd7b0f6f8564e8$$aKraft, Bianca$$b0$$eFirst author$$udkfz
000143232 245__ $$aSMC3 protein levels impact on karyotype and outcome in acute myeloid leukemia.
000143232 260__ $$aLondon$$bSpringer Nature$$c2019
000143232 3367_ $$2DRIVER$$aarticle
000143232 3367_ $$2DataCite$$aOutput Types/Journal article
000143232 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1554213740_30312
000143232 3367_ $$2BibTeX$$aARTICLE
000143232 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143232 3367_ $$00$$2EndNote$$aJournal Article
000143232 536__ $$0G:(DE-HGF)POF3-311$$a311 - Signalling pathways, cell and tumor biology (POF3-311)$$cPOF3-311$$fPOF III$$x0
000143232 588__ $$aDataset connected to CrossRef, PubMed,
000143232 7001_ $$0P:(DE-HGF)0$$aLombard, Jan$$b1
000143232 7001_ $$0P:(DE-He78)7f89263a113835ee52f6fc4f38bc0dcb$$aKirsch, Michael$$b2$$udkfz
000143232 7001_ $$aWuchter, Patrick$$b3
000143232 7001_ $$aBugert, Peter$$b4
000143232 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b5$$udkfz
000143232 7001_ $$aBlank, Norbert$$b6
000143232 7001_ $$0P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0$$aKrämer, Alwin$$b7$$eLast author$$udkfz
000143232 773__ $$0PERI:(DE-600)2008023-2$$a10.1038/s41375-018-0287-6$$gVol. 33, no. 3, p. 795 - 799$$n3$$p795 - 799$$tLeukemia$$v33$$x1476-5551$$y2019
000143232 909CO $$ooai:inrepo02.dkfz.de:143232$$pVDB
000143232 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a3903480c7232195efbd7b0f6f8564e8$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000143232 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000143232 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7f89263a113835ee52f6fc4f38bc0dcb$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000143232 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000143232 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000143232 9131_ $$0G:(DE-HGF)POF3-311$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vSignalling pathways, cell and tumor biology$$x0
000143232 9141_ $$y2019
000143232 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143232 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143232 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLEUKEMIA : 2017
000143232 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143232 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000143232 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000143232 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143232 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143232 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143232 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143232 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000143232 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143232 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bLEUKEMIA : 2017
000143232 9201_ $$0I:(DE-He78)A360-20160331$$kA360$$lKKE Molekulare Hämatologie/Onkologie$$x0
000143232 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x1
000143232 980__ $$ajournal
000143232 980__ $$aVDB
000143232 980__ $$aI:(DE-He78)A360-20160331
000143232 980__ $$aI:(DE-He78)C060-20160331
000143232 980__ $$aUNRESTRICTED